Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
2014 · European Urology · 248 citations
https://doi.org/10.1016/j.eururo.2014.01.003
A
Allan D. Spigelman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
258
Papers
7.1K
Citations
44
h-index
103
i10-index
Allan D. Spigelman is an academic researcher from Cancer Institute of New South Wales. The author has contributed to research in topics: Genetic factors in colorectal cancer & Colorectal Cancer Screening and Detection & Gastric Cancer Management and Outcomes. The author has an h-index of 44, co-authored 220 publications.
ORCID: 0000-0002-7409-1684Papers by this author
worksInterim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
2019 · European Urology · 234 citations
https://doi.org/10.1016/j.eururo.2019.08.019
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
2019 · Nature Communications · 138 citations
https://doi.org/10.1038/s41467-018-08053-5
Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study
2021 · The Lancet Oncology · 112 citations
https://doi.org/10.1016/s1470-2045(21)00189-3
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
2021 · The Lancet Oncology · 89 citations
https://doi.org/10.1016/s1470-2045(21)00522-2
Homologous recombination DNA repair defects in PALB2-associated breast cancers
2019 · npj Breast Cancer · 57 citations
https://doi.org/10.1038/s41523-019-0115-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat